Resultados de procura - Yifan Zhai
- Mostrando 1 - 15 Resultados de 15
-
1
-
2
-
3
-
4
LIGHT, a TNF-Like Molecule, Costimulates T Cell Proliferation and Is Required for Dendritic Cell-Mediated Allogeneic T Cell Response por Koji Tamada, Koji Shimozaki, Andrei I. Chapoval, Yifan Zhai, Jeffery Su, Su-Fang Chen, Shie‐Liang Hsieh, Shigekazu Nagata, Jian Ni, Lieping Chen
Publicado 2000Artigo -
5
Cloning and Characterization of the Genes Encoding the Murine Homoloties of the Human Melanoma Antigens MARTI and gp100 por Yifan Zhai, James Chih‐Hsin Yang, Paul J. Spiess, Michael I. Nishimura, Willem W. Overwijk, Bruce Roberts, Nicholas P. Restifo, Steven A. Rosenberg
Publicado 1997Artigo -
6
MDM2 inhibitor APG-115 synergizes with PD-1 blockade through enhancing antitumor immunity in the tumor microenvironment por Douglas D. Fang, Qiuqiong Tang, Yanhui Kong, Qixin Wang, Jiaxing Gu, Fang Xu, Peng Zou, Rong Tao, Jingwen Wang, Dajun Yang, Yifan Zhai
Publicado 2019Artigo -
7
Cutting Edge: TRANK, a Novel Cytokine That Activates NF-κB and c-Jun N-Terminal Kinase por Valsala Haridas, Jian Ni, Anthony Meager, Jeffery Su, Guo-Liang Yu, Yifan Zhai, Hla Kyaw, Keith T. Akama, Jingru Hu, Linda J. Van Eldik, Bharat B. Aggarwal
Publicado 1998Artigo -
8
MDM2 inhibitor APG-115 exerts potent antitumor activity and synergizes with standard-of-care agents in preclinical acute myeloid leukemia models por Douglas D. Fang, Qiuqiong Tang, Yanhui Kong, Rong Tao, Qixin Wang, Na Li, F. Xu, Jiaxing Gu, Dengkun Xiong, Yan Yin, Jing Deng, Dajun Yang, Yifan Zhai
Publicado 2021Artigo -
9
A novel small molecule inhibitor of MDM2-p53 (APG-115) enhances radiosensitivity of gastric adenocarcinoma por Hanjie Yi, Xianglei Yan, Qiuyun Luo, Luping Yuan, Baoxia Li, Wentao Pan, Lin Zhang, Haibo Chen, Jing Wang, Yu Zhang, Yifan Zhai, Miao‐Zhen Qiu, Da-Jun Yang
Publicado 2018Artigo -
10
Immunizing Patients With Metastatic Melanoma Using Recombinant Adenoviruses Encoding MART-1 or gp100 Melanoma Antigens por Steven A. Rosenberg, Yifan Zhai, J. C. Yang, Douglas J. Schwartzentruber, P. Hwu, Francesco M. Marincola, Suzanne L. Topalian, Nicholas P. Restifo, Claudia A. Seipp, Jan Einhorn, Donald E. White, Bruce Roberts
Publicado 1998Artigo -
11
Discovery of 4-((3′<i>R</i>,4′<i>S</i>,5′<i>R</i>)-6″-Chloro-4′-(3-chloro-2-fluorophenyl)-1′-ethyl-2″-oxodispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-indoline]-5′-carboxamido)bicyclo... por Angelo Aguilar, Jianfeng Lü, Liu Liu, Ding Du, Denzil Bernard, Donna McEachern, Sally Przybranowski, Xiaoqin Li, Ruijuan Luo, Bo Wen, Duxin Sun, Hengbang Wang, Jianfeng Wen, Guangfeng Wang, Yifan Zhai, Ming Guo, Dajun Yang, Shaomeng Wang
Publicado 2017Artigo -
12
Novel BCL-2 Inhibitor Lisaftoclax in Relapsed or Refractory Chronic Lymphocytic Leukemia and Other Hematologic Malignancies: First-in-Human Open-Label Trial por Sikander Ailawadhi, Zi Chen, Bo Huang, Aneel Paulus, Mary C. Collins, Lei Fu, Mingyu Li, Mohammad Ahmad, Lichuang Men, Hengbang Wang, Matthew S. Davids, Eric Liang, Divya J. Mekala, Zhicong He, Masa Lasica, Costas K. Yannakou, Ricardo Parrondo, Laura Glass, Dajun Yang, Asher Chanan‐Khan, Yifan Zhai
Publicado 2023Artigo -
13
Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter p... por Qian Jiang, Zongru Li, Ya‐Zhen Qin, Wei‐Ming Li, Na Xu, Bingcheng Liu, Yanli Zhang, Meng Li, Huanling Zhu, Xin Du, Suning Chen, Yang Liang, Yu Hu, Xiaoli Liu, Yongping Song, Lichuang Men, Zi Chen, Qian Niu, Hengbang Wang, Ming Lu, Dajun Yang, Yifan Zhai, Xiao‐Jun Huang
Publicado 2022Artigo -
14
BH3 mimetics targeting BCL-XL impact the senescent compartment of pilocytic astrocytoma por Florian Selt, Romain Sigaud, Gintvile Valinciute, Philipp Sievers, Julia Zaman, Clara Alcon, Simone Schmid, Heike Peterziel, Jessica W. Tsai, Romain Guiho, Juan Pedro Martı́nez-Barberá, Stefan Pusch, Jing Deng, Yifan Zhai, Cornelis M. van Tilburg, Martin U Schuhman, Ahmed El Damaty, Pratiti Bandopadhayay, Christel Herold‐Mende, Andreas von Deimling, Stefan M. Pfister, Joan Montero, David Capper, Ina Oehme, Felix Sahm, David Jones, Olaf Witt, Till Milde
Publicado 2022Artigo -
15
Lisaftoclax (APG-2575) Is a Novel BCL-2 Inhibitor with Robust Antitumor Activity in Preclinical Models of Hematologic Malignancy por Jing Deng, Aneel Paulus, Douglas D. Fang, Alak Manna, Guangfeng Wang, Hengbang Wang, Saijie Zhu, Jianyong Chen, Ping Min, Yan Yin, Navnita Dutta, Nabanita Halder, Gina Ciccio, John A. Copland, James L. Miller, Bing Han, Longchuan Bai, Liu Liu, Mi Wang, Donna McEachern, Sally Przybranowski, Chao‐Yie Yang, Jeanne A. Stuckey, Depei Wu, Caixia Li, Jeremy Ryan, Anthony Letai, Sikander Ailawadhi, Dajun Yang, Shaomeng Wang, Asher Chanan‐Khan, Yifan Zhai
Publicado 2022Artigo
Ferramentas de procura:
Materias Relacionadas
Biology
Biochemistry
Cancer research
Gene
Genetics
Immunology
Medicine
Apoptosis
Internal medicine
Pharmacology
In vivo
Biotechnology
Cell biology
Chemistry
Leukemia
Mdm2
Peptide sequence
Receptor
Adverse effect
Antigen
Cancer
Cell cycle
Cell cycle checkpoint
Chronic lymphocytic leukemia
Gastroenterology
Gene expression
Immune system
In vitro
Kinase
Melanoma